Insys Therapeutics Price Target & Analyst Ratings (NASDAQ:INSY)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

4 Wall Street analysts have issued ratings and price targets for Insys Therapeutics in the last 12 months. Their average twelve-month price target is $6.60The high price target for INSY is $11.00 and the low price target for INSY is $4.00. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."

Insys Therapeutics (NASDAQ:INSY) Consensus Price Target History

Insys Therapeutics (NASDAQ:INSY) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/14/2019	Janney Montgomery Scott	Downgrade	Buy ➝ Neutral		High
3/8/2019	Piper Jaffray Companies	Set Price Target	Sell	$4.00	Medium
3/8/2019	Royal Bank of Canada	Lower Price Target	Outperform ➝ Outperform	$9.00 ➝ $7.00	High
1/22/2019	Cantor Fitzgerald	Initiated Coverage	Overweight	$4.40	High
8/10/2018	Jefferies Financial Group	Reiterated Rating	Buy	$10.00	Low
5/9/2018	Oppenheimer	Reiterated Rating	Hold		Low

(Data available from 10/19/2017 forward)